vida: extract claims from 2026-04-08-obbba-medicaid-work-requirements-timeline

- Source: inbox/queue/2026-04-08-obbba-medicaid-work-requirements-timeline.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 1
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/double-coverage-compression-simultaneous-medicaid-cuts-and-aptc-expiry-eliminate-coverage-for-under-400-fpl.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: OBBBA creates a pincer movement where both major coverage sources for low-income populations contract at the same time for different income bands
+confidence: experimental
+source: AMA analysis of OBBBA provisions; APTC expiry 2026 confirmed
+created: 2026-04-08
+title: Double coverage compression occurs when Medicaid work requirements contract coverage below 138 percent FPL while APTC expiry eliminates subsidies for 138-400 percent FPL simultaneously
+agent: vida
+scope: structural
+sourcer: AMA
+related_claims: ["[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]"]
+---
+
+# Double coverage compression occurs when Medicaid work requirements contract coverage below 138 percent FPL while APTC expiry eliminates subsidies for 138-400 percent FPL simultaneously
+
+OBBBA creates what can be termed 'double coverage compression'—the simultaneous contraction of both major coverage pathways for low-income populations. Medicaid work requirements affect populations below 138% FPL (the Medicaid expansion threshold), while APTC (Advance Premium Tax Credits) expired in 2026 without extension in OBBBA, affecting populations from 138-400% FPL who rely on marketplace subsidies. This is not sequential policy change—it's simultaneous compression of coverage from both ends of the low-income spectrum. The mechanism matters because it eliminates the safety net redundancy that previously existed: when someone lost Medicaid eligibility, marketplace subsidies provided a fallback; when marketplace became unaffordable, Medicaid expansion provided coverage. With both contracting simultaneously, there is no fallback layer. This creates a coverage cliff rather than a coverage gradient. The AMA analysis explicitly identifies this interaction, noting that both coverage sources are 'simultaneously contracting for different income bands.' This is distinct from either policy change in isolation—the interaction effect creates a coverage gap that neither policy alone would produce.

domains/health/glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: "Discontinuation produces rapid rebound: 40% of semaglutide weight loss regained in 28 weeks, 50% of tirzepatide loss in 52 weeks, with cardiovascular and glycemic markers also reversing"
+confidence: likely
+source: Tzang et al., Lancet eClinicalMedicine meta-analysis of 18 RCTs (n=3,771)
+created: 2026-04-08
+title: GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation
+agent: vida
+scope: causal
+sourcer: Tzang et al. (Lancet eClinicalMedicine)
+related_claims: ["[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"]
+---
+
+# GLP-1 receptor agonists require continuous treatment because metabolic benefits reverse within 28-52 weeks of discontinuation
+
+Meta-analysis of 18 randomized controlled trials (n=3,771) demonstrates that GLP-1 receptor agonist benefits require continuous treatment. After discontinuation, mean weight gain was 5.63 kg, with 40%+ of semaglutide-induced weight loss regained within 28 weeks and 50%+ of tirzepatide loss regained within 52 weeks. Nonlinear meta-regression predicts return to pre-treatment weight levels within <2 years. Critically, the rebound extends beyond weight: waist circumference, BMI, systolic blood pressure, HbA1c, fasting plasma glucose, cholesterol, and blood pressure all deteriorate post-discontinuation. STEP-10 and SURMOUNT-4 trials confirmed substantial weight regain, glycemic control deterioration, and reversal of lipid/blood pressure improvements. While individualized dose-tapering can limit (but not prevent) rebound, no reliable long-term strategy for weight management after cessation exists. This continuous-treatment dependency means GLP-1 efficacy at the population level requires permanent access infrastructure, not just drug availability. Coverage gaps of 3-6 months—common under Medicaid redetermination cycles—can fully reverse therapeutic benefits that took months to achieve.

domains/health/obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: Mandatory work requirements create coverage churning that eliminates the 12-36 month enrollment continuity VBC models need to demonstrate prevention paybacks
+confidence: likely
+source: AMA, Georgetown CCF, Urban Institute, Modern Medicaid Alliance convergence; Arkansas implementation data showing 18,000 coverage losses despite work compliance
+created: 2026-04-08
+title: OBBBA Medicaid work requirements destroy the enrollment stability that value-based care requires for prevention ROI by forcing all 50 states to implement 80-hour monthly work thresholds by December 2026
+agent: vida
+scope: structural
+sourcer: AMA / Georgetown CCF / Urban Institute
+related_claims: ["[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]"]
+---
+
+# OBBBA Medicaid work requirements destroy the enrollment stability that value-based care requires for prevention ROI by forcing all 50 states to implement 80-hour monthly work thresholds by December 2026
+
+OBBBA requires all states to implement Medicaid work requirements (80+ hours/month for ages 19-64) by December 31, 2026, with CMS issuing implementation guidance by June 1, 2026. This creates a structural conflict with value-based care economics. VBC models require 12-36 month enrollment stability to demonstrate prevention ROI—investments in preventive care today only pay back through reduced acute care costs over multi-year horizons. Work requirements destroy this stability through two mechanisms: (1) operational barriers that cause eligible members to lose coverage (Arkansas lost 18,000 enrollees pre-2019, most of whom were working but couldn't navigate reporting; Georgia PATHWAYS documentation burden resulted in eligible members losing coverage), and (2) employment volatility that creates coverage gaps even for compliant members. The December 2026 deadline means this is not a pilot—it's a national structural change affecting all states simultaneously. Seven states (Arizona, Arkansas, Iowa, Montana, Ohio, South Carolina, Utah) already have pending waivers at CMS, indicating early implementation attempts. This directly undermines the VBC transition pathway because prevention investment becomes structurally unprofitable when the population churns before payback periods complete. The Urban Institute projects significant enrollment declines, and CBO estimates 10M additional uninsured by 2034 from combined OBBBA provisions. This is not just coverage reduction—it's the destruction of the enrollment continuity architecture that makes VBC economically viable.

domains/health/us-cardiovascular-mortality-gains-reversing-after-decades-of-improvement-across-major-conditions.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: JACC reports mortality trends reversing for coronary heart disease, acute MI, heart failure, peripheral artery disease, and stroke
+confidence: likely
+source: JACC Cardiovascular Statistics 2026, American College of Cardiology
+created: 2026-04-08
+title: Long-term US cardiovascular mortality gains are slowing or reversing across major conditions as of 2026 after decades of continuous improvement
+agent: vida
+scope: structural
+sourcer: American College of Cardiology
+related_claims: ["[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations]]"]
+---
+
+# Long-term US cardiovascular mortality gains are slowing or reversing across major conditions as of 2026 after decades of continuous improvement
+
+The JACC 2026 Cardiovascular Statistics report documents that long-term mortality gains are 'slowing or reversing' across coronary heart disease, acute MI, heart failure, peripheral artery disease, and stroke. Heart failure mortality specifically has been increasing since 2012 and is now 3% higher than 25 years ago. The HF population is projected to grow from 6.7M (2026) to 11.4M (2050). Black adults are experiencing the fastest HF mortality rate increase, particularly under age 65. This reversal follows decades of continuous improvement in CVD mortality and represents a fundamental shift in the epidemiological trajectory. The JACC chose to launch their inaugural annual statistics series with this data, signaling institutional recognition of a crisis. The pattern suggests the healthcare system has exhausted gains from acute intervention (stents, clots, surgery) while failing to address chronic disease management and prevention at population scale.

domains/health/us-hypertension-mortality-doubled-2000-2019-while-treatment-control-stagnated-structural-access-failure.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: Hypertension deaths rose from 23 to 43 per 100,000 despite flat treatment rates indicating system design and access barriers rather than therapeutic gaps
+confidence: likely
+source: JACC Cardiovascular Statistics 2026, American College of Cardiology
+created: 2026-04-08
+title: US hypertension-related cardiovascular mortality nearly doubled from 2000 to 2019 while treatment and control rates stagnated for 15 years demonstrating structural access failure not drug unavailability
+agent: vida
+scope: structural
+sourcer: American College of Cardiology
+related_claims: ["[[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]]", "[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]"]
+---
+
+# US hypertension-related cardiovascular mortality nearly doubled from 2000 to 2019 while treatment and control rates stagnated for 15 years demonstrating structural access failure not drug unavailability
+
+The JACC inaugural Cardiovascular Statistics report documents that hypertension-related cardiovascular deaths nearly doubled from 23 to 43 per 100,000 population between 2000 and 2019, while treatment and control rates have remained stagnant for 15 years. Nearly 1 in 2 US adults meet current hypertension criteria. This pattern reveals a structural failure: the medical system possesses effective antihypertensive drugs but cannot deliver treatment and achieve control at population scale. The stagnation in treatment/control rates despite rising mortality indicates the bottleneck is not pharmaceutical innovation but rather access, adherence, care coordination, and system design. Disparities persist with higher rates in men and Black adults. This is the proxy inertia mechanism operating at healthcare system scale—existing profitable structures (episodic sick care, fragmented delivery) rationally resist reorganization toward prevention-focused continuous care even as population health deteriorates.

inbox/archive/health/2026-04-08-obbba-medicaid-work-requirements-timeline.md

@@ -7,9 +7,12 @@ date: 2026-01-23
 domain: health
 secondary_domains: []
 format: report
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-08
 priority: high
 tags: [OBBBA, Medicaid, work-requirements, coverage-loss, access, implementation, VBC, policy]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content